Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-10,099
Closed -$247K 496
2020
Q3
$247K Buy
+10,099
New +$236K 0.01% 543
2019
Q4
Sell
-37,400
Closed -$661K 648
2019
Q3
$661K Hold
37,400
0.01% 445
2019
Q2
$799K Buy
37,400
+300
+0.8% +$6.29K 0.02% 419
2019
Q1
$883K Buy
+37,100
New +$846K 0.02% 424

Other funds holding EXEL

Barings's EXEL Position: Q4 2020 in Review

Barings sold out of Exelixis (EXEL) in Q4 2020, closing a stake of 10,099 shares — an estimated $247K sold.

Barings first reported a position in EXEL in Q1 2019 and held it in 4 quarters. The position peaked at $883K in Q1 2019. 351 funds tracked by Wall St. Rank hold EXEL as of Q4 2020.

  • Barings reported no remaining Exelixis position as of Q4 2020 after selling out during the quarter.
  • Barings sold 10,099 Exelixis shares in Q4 2020, an estimated $247K.
  • Barings first reported a position in Exelixis in Q1 2019 and held it in 4 quarters.
  • Barings's Exelixis position peaked at $883K in Q1 2019.
  • 351 funds tracked by Wall St. Rank held Exelixis as of Q4 2020.

Based on Barings's 13F filing for Q4 2020, filed 16 Feb 2021.